WallStreetZenWallStreetZen

NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Stock Ownership - Who owns Lexicon Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lexicon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael ExtonCEO2026-11-0630,064$1.66
$50.00kBuy
Scott M. CoianteSVP Chief Financial Officer2026-02-2854,881$1.47
$80.68kSell
Brian T. CrumSVP General Counsel Secr.2026-02-28105,019$1.47
$154.38kSell
Wendy McDermottSVP Human Resources2026-02-2868,107$1.47
$100.12kSell
Lisa DefrancescoSVP IR and Corp Comm2026-02-2874,572$1.47
$109.62kSell
Michael ExtonChief Executive Officer2026-02-28204,831$1.47
$301.10kSell
Suma GopinathanSVP Discovery2026-02-2824,338$1.47
$35.78kSell
Craig B. GranowitzSVP Chief Medical Officer2026-02-28109,098$1.47
$160.37kSell
Rachel Yap MartensSVP Partnerships Corp Strat2026-02-2835,826$1.47
$52.66kSell
Raymond DebbaneDirector2026-02-252,000$1.49
$2.98kBuy

1 of 3

LXRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXRX insiders and whales buy or sell their stock.

LXRX Shareholders

What type of owners hold Lexicon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Raymond Debbane80.99%360,586,095$656.27MInsider
International Sca Artal71.55%318,557,433$579.77MInsider
Participations Sa Rl Artal69.93%311,336,543$566.63MInsider
Invus Public Equities LP7.95%35,402,689$64.43MInsider
Amaury Wittouck7.95%35,402,689$64.43MInsider
Siren LLC7.95%35,402,689$64.43MInsider
Cv Invus6.79%30,248,505$55.05MInsider
Invus Us Partners LLC1.30%5,782,749$10.52MInsider
Ulys LLC1.25%5,553,292$10.11MInsider
Invus Partners LLC0.97%4,321,214$7.86MInsider

1 of 3

LXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXRX0.03%99.97%Net BuyingNet Buying
ALMS0.09%28.51%Net BuyingNet Buying
RIGL0.07%99.93%Net SellingNet Selling
OBX0.00%0.05%
ANNX0.09%15.08%Net BuyingNet Buying
View Top Biotech Stocks

Lexicon Pharmaceuticals Stock Ownership FAQ

Who owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals (NASDAQ: LXRX) is owned by 0.08% institutional shareholders, 259.44% Lexicon Pharmaceuticals insiders, and 0.00% retail investors. Raymond Debbane is the largest individual Lexicon Pharmaceuticals shareholder, owning 360.59M shares representing 80.99% of the company. Raymond Debbane's Lexicon Pharmaceuticals shares are currently valued at $670.69M.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.